We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+37.44%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.04B
AUM Growth
+$198M
Cap. Flow
+$14M
Cap. Flow %
1.35%
Top 10 Hldgs %
42.78%
Holding
150
New
56
Increased
28
Reduced
29
Closed
29

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$12.9M
2
LHCG
LHC Group LLC
LHCG
+$9.74M
3
CNMD icon
CONMED
CNMD
+$7.65M
4
LIVN icon
LivaNova
LIVN
+$7.59M
5
IMVT icon
Immunovant
IMVT
+$5.8M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.47M
2
XLRN
Acceleron Pharma
XLRN
+$5.43M
3
STAA icon
STAAR Surgical
STAA
+$5.36M
4
QDEL icon
QuidelOrtho
QDEL
+$5.09M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 38.45%
2 Industrials 1.39%
3 Energy 1.11%
4 Consumer Discretionary 0.31%
5 Consumer Staples 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
126
Castle Biosciences
CSTL
$967M
– –
-110,899
Closed -$3.31M
EOLS icon
127
Evolus
EOLS
$540M
– –
-141,442
Closed -$651K
GILD icon
128
CALL
Gilead Sciences
GILD
$168B
– –
-55,000
Closed -$4.11M
GILD icon
129
Gilead Sciences
GILD
$168B
– –
-50,000
Closed -$3.74M
KALA icon
130
PUT
KALA BIO
KALA
$16.8M
– –
-175
Closed -$3.84M
LLY icon
131
PUT
Eli Lilly
LLY
$1.09T
– –
-150,000
Closed -$20.8M
MDT icon
132
CALL
Medtronic
MDT
$116B
– –
-475,000
Closed -$42.8M
MTUM icon
133
PUT
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
– –
-60,000
Closed -$6.39M
NGNE icon
134
Neurogene
NGNE
$731M
– –
-4,870
Closed -$1.11M
PBYI icon
135
Puma Biotechnology
PBYI
$456M
– –
-64,000
Closed -$540K
QDEL icon
136
QuidelOrtho
QDEL
$1B
– –
-51,999
Closed -$5.09M
QQQ icon
137
PUT
Invesco QQQ Trust
QQQ
$482B
– –
-67,500
Closed -$12.9M
REGN icon
138
Regeneron Pharmaceuticals
REGN
$82.4B
– –
-11,212
Closed -$5.47M
RNAC icon
139
Cartesian Therapeutics
RNAC
$260M
– –
-20,825
Closed -$1.51M
TMO icon
140
PUT
Thermo Fisher Scientific
TMO
$222B
– –
-27,500
Closed -$7.8M
ZBH icon
141
CALL
Zimmer Biomet
ZBH
$18.4B
– –
-10,300
Closed -$1.01M
NVRO
142
DELISTED
NEVRO CORP.
NVRO
– –
-20,000
Closed -$2.37M
CBAY
143
CALL
DELISTED
Cymabay Therapeutics
CBAY
– –
-354,000
Closed -$524K
PPD
144
DELISTED
PPD, Inc. Common Stock
PPD
– –
-205,000
Closed -$3.65M
VAR
145
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-52,500
Closed -$5.39M
IMMU
146
PUT
DELISTED
Immunomedics Inc
IMMU
– –
-165,600
Closed -$2.23M
IMVTU
147
DELISTED
Immunovant, Inc. Units
IMVTU
– –
-175,010
Closed -$2.9M
HZNP
148
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-32,816
Closed -$972K
2 3 4 5
6

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q2 2020 Portfolio in Review

As of Q2 2020, Pura Vida Investments held 150 positions worth $1.04B, up 23% from $842M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Pura Vida Investments's Q2 2020 filing shows 56 new, 28 increased, 29 reduced and 29 closed positions. Its largest new stake was LHC Group LLC: 66,359 shares worth $11.6M. The largest sale was Regeneron Pharmaceuticals, an estimated $5.47M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Industrials and Energy.

  • Pura Vida Investments's largest Q2 2020 buy was LHC Group LLC: 66,359 shares worth $11.6M.
  • Pura Vida Investments added most to AtriCure in Q2 2020, an estimated $12.9M increase.
  • Pura Vida Investments's biggest Q2 2020 reduction was Acceleron Pharma, cutting an estimated $5.43M.
  • Pura Vida Investments fully exited Regeneron Pharmaceuticals in Q2 2020, selling an estimated $5.47M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $1.04B portfolio in Q2 2020.
  • Pura Vida Investments opened 56 new positions and closed 29 in Q2 2020.
  • Pura Vida Investments's portfolio value rose 23% quarter-over-quarter to $1.04B.

Based on Pura Vida Investments's 13F filing for Q2 2020, filed 14 Aug 2020.